Cullinan Therapeutics (CGEM) Interest & Investment Income (2021 - 2023)
Historic Interest & Investment Income for Cullinan Therapeutics (CGEM) over the last 3 years, with Q4 2023 value amounting to $5.9 million.
- Cullinan Therapeutics' Interest & Investment Income rose 7589.18% to $5.9 million in Q4 2023 from the same period last year, while for Dec 2023 it was $21.6 million, marking a year-over-year increase of 22713.66%. This contributed to the annual value of $29.7 million for FY2024, which is 3714.34% up from last year.
- According to the latest figures from Q4 2023, Cullinan Therapeutics' Interest & Investment Income is $5.9 million, which was up 7589.18% from $5.9 million recorded in Q3 2023.
- In the past 5 years, Cullinan Therapeutics' Interest & Investment Income registered a high of $5.9 million during Q4 2023, and its lowest value of $49000.0 during Q1 2021.
- For the 3-year period, Cullinan Therapeutics' Interest & Investment Income averaged around $2.4 million, with its median value being $1.5 million (2022).
- As far as peak fluctuations go, Cullinan Therapeutics' Interest & Investment Income soared by 235547.45% in 2022, and later surged by 7589.18% in 2023.
- Over the past 3 years, Cullinan Therapeutics' Interest & Investment Income (Quarter) stood at $137000.0 in 2021, then soared by 2355.47% to $3.4 million in 2022, then surged by 75.89% to $5.9 million in 2023.
- Its Interest & Investment Income was $5.9 million in Q4 2023, compared to $5.9 million in Q3 2023 and $5.3 million in Q2 2023.